G2211 in Orthopaedic E&M Coding: The 2026 Rules, the Modifier 25 Trap, and CMS's Proposed 2027 Replacement

HCPCS G2211 is a Medicare add-on code that orthopaedic practices can report with an office or outpatient E/M visit when the surgeon or advanced practice provider is the continuing focal point for a patient's care or is managing a single serious or complex condition over time. In orthopaedics, that typically means ongoing management of a chronic condition such as osteoarthritis, not a one-time consult or an episode of fracture care.

The biggest limitation for orthopaedics is modifier 25: G2211 is not payable when the E/M visit carries modifier 25 because a separately payable procedure, such as a joint injection, was performed the same day. For 2027, CMS has proposed replacing G2211 with a payment modifier worth 16 percent of the E/M payment and cutting payment for same-day E/M visits billed with 0, 10, and 90 day global procedures. The final rule is expected around November 2026.

This guide explains who can use G2211 in an orthopaedic practice, where it does not apply, how to document it, and how the 2027 proposal changes the math.

What G2211 is

CMS describes G2211 as "visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition, or a complex condition." It became separately payable on January 1, 2024 under the CY2024 Medicare Physician Fee Schedule final rule.

The code carries a work RVU of 0.33 and was worth about $16 nationally in 2024. It was originally limited to office and outpatient E/M visits (99202 to 99215). Beginning January 1, 2026, CMS extended it to home or residence E/M visits as well. The usual Part B deductible and coinsurance apply, so patients see it on their statements.

G2211 is not specialty restricted. CMS's own FAQ uses specialist examples, such as an infectious disease physician managing HIV. What qualifies a visit is the relationship between the practitioner and the patient's ongoing care, not the practitioner's specialty or whether the patient is new or established.

Why orthopaedic practices underuse it and sometimes misuse it

Adoption across Medicare has been slower than CMS projected. CMS assumed G2211 would be billed on 38 percent of eligible office visits at launch, rising to 54 percent at full adoption. A February 2026 study in JAMA found about 26 million G2211 claims across more than 10 million traditional Medicare patients in 2024, with nearly $400 million paid, and roughly one in four physicians billing it. An April 2026 study in Annals of Internal Medicine using Epic Cosmos data found use rising from 5 percent of Medicare visits to about 27 percent by mid-2025.

That gap matters to every practice, not just those that bill G2211. Because the fee schedule is budget neutral, CMS's utilization assumption reduced payment rates for all physicians. The AMA estimates the overestimate cut rates by more than 1 percent starting in 2024, and CMS declined to correct it for 2026. An orthopaedic group that never bills G2211 is still paying for it.

Orthopaedic practices face two opposite risks:

• Underuse: surgeons and APPs who manage patients with chronic musculoskeletal conditions over years often never add G2211 because nobody built it into the visit template or charge review.
• Misuse: templates that add G2211 to every established visit, including visits with same-day injections or episodic injury care, create a predictable denial and audit pattern.

Where G2211 applies in an orthopaedic practice

CMS has not published orthopaedic-specific examples, so practices need to apply the general standard carefully. The CMS FAQ says G2211 is not appropriate when the practitioner "has not taken responsibility for ongoing medical care for a given patient with consistency and continuity over time." CMS does not define a minimum number of visits, a required diagnosis, or a specific time horizon.

Reasonable orthopaedic scenarios to evaluate include:

• A surgeon or APP who manages a patient's knee or hip osteoarthritis across repeat visits, adjusting activity modification, bracing, physical therapy, and imaging over time, where the visit does not include a same-day procedure.
• Ongoing management of a chronic spine condition where the orthopaedic practice is directing the patient's care plan.
• A new patient visit that establishes a longitudinal relationship for a chronic condition the practice will continue to manage. CMS guidance and the 2026 descriptor both reference new or established patients.

In each case, the record needs to show that the practice has taken responsibility for the patient's ongoing care of that condition.

Where G2211 does not apply

Visits with modifier 25 and a same-day procedure

This is the rule that affects orthopaedics most. CMS's original 2024 edits denied G2211 on any office or outpatient E/M reported with modifier 25. In the CY2025 fee schedule, CMS created a narrow exception: G2211 is payable with a modifier 25 E/M only when the other same-day service is an annual wellness visit, vaccine administration, or a Medicare Part B preventive service.

Joint injections, aspirations, casting, and other orthopaedic procedures are not on that list. Noridian's guidance, updated February 2026, states that G2211 is not payable when the E/M service is reported with modifier 25 on the same day as another separately payable procedure. So a 99214 with modifier 25 and 20610 for a knee injection does not support G2211, even if the patient has been under the surgeon's care for osteoarthritis for five years.

Episodic and time-limited care

The CMS FAQ lists relationships of a discrete, routine, or time-limited nature as inappropriate for G2211, and "treatment for a fracture" is one of CMS's examples. A patient seen for an ankle sprain, a single second opinion, or a one-time consult for a surgical question does not have the continuous relationship G2211 describes.

Visits inside a global surgical period

Postoperative visits related to the surgery during a 10 or 90 day global period are bundled into the surgical payment and reported with 99024, so there is no separately payable E/M for G2211 to attach to. CMS has not issued G2211 guidance specific to global periods, but the logic follows from the global surgery rules. An unrelated E/M during the global period reported with modifier 24 is a different question; evaluate whether it meets the longitudinal standard on its own facts, and check payer policy.

Non-Medicare payers that do not recognize it

Medicare Advantage and commercial payers are not required to pay G2211. Several large Medicare Advantage plans announced coverage in 2024, while at least one major commercial plan reportedly ended coverage later that year. Confirm each payer's current policy before adding G2211 to commercial claims.

How to document G2211

CMS does not require specific additional documentation, but medical reviewers can look at the record to confirm medical necessity and the continuing relationship. Noridian has cautioned that templated language may not support medical necessity and that a statement like "patient is complex" alone is not enough.

For orthopaedic visits, strong documentation typically includes:

• The condition being managed longitudinally, named specifically, for example "primary osteoarthritis, right knee (M17.11)."
• The practice's ongoing role, for example "I am managing this patient's knee osteoarthritis and will continue to follow her every three to four months."
• How today's visit fits the longer plan, such as changes to the treatment plan, response to prior interventions, and the next planned step.
• No same-day separately payable procedure, or, if there was one, no G2211 on the claim.

The E/M level itself still stands on medical decision making or time under the AMA's 2021 office visit guidelines. G2211 does not raise the level, and the level does not determine eligibility for G2211.

What CMS proposed for 2027

On July 14, 2026, CMS released the CY2027 Physician Fee Schedule proposed rule (CMS-1848-P). The comment period closed September 14, 2026. Two proposals directly change the G2211 calculation for orthopaedic practices.

G2211 would become a percentage modifier

CMS proposed replacing the G2211 add-on code with a modifier (called MOD1 in the proposal) that would increase the E/M payment by 16 percent, rather than adding a flat amount. A second modifier (MOD2) would increase payment by 32 percent for Medicare Shared Savings Program ACO and LEAD model participants, and the two could not be billed together. The 16 percent reflects the utilization-weighted average value of G2211 relative to the base visit codes, adjusted for budget neutrality.

The practical effect is that the add-on would scale with the visit level. Because today's G2211 is a flat amount, it is worth proportionally more on a lower-level visit and proportionally less on a higher-level one. A percentage modifier reverses that. For orthopaedic practices where longitudinal chronic care visits tend to be moderate complexity, the change could be modestly favorable, but it also raises the stakes on getting the E/M level right, since any undercoding now shrinks the add-on too.

The modifier 25 restriction would carry over. CMS did request comment on whether to lift it when modifier 25 is used for same-day procedures with 0, 10, or 90 day global periods, which would matter to orthopaedics more than almost any other specialty.

Same-day E/M and procedures would be paid at 50 percent

CMS also proposed that when a separately identifiable office or outpatient E/M visit is billed with modifier 25 by the same physician or practice on the same day as a 0, 10, or 90 day global procedure, the most expensive service would be paid at 100 percent and all other procedures or E/M visits that day would be paid at 50 percent. CMS asked whether 25 percent would be more appropriate. This would apply to correctly coded claims, not just errors.

CMS lists orthopaedic surgery among the specialties facing a significant payment decrease under the proposed rule. AAOS opposed the same-day reduction in a September 14, 2026 comment letter, and the AMA-led Federation of medical societies also commented against it. The final rule typically arrives around the start of November and takes effect January 1.

What orthopaedic practices should do now

1. Audit your 2026 G2211 use. Pull every G2211 claim and check for same-day modifier 25 procedures, episodic diagnoses, and global period visits. Correct any systemic template issue before it becomes a pattern.
2. Find the missed opportunities. Identify patients with chronic orthopaedic conditions managed longitudinally, seen without same-day procedures, and without G2211.
3. Separate the injection decision from the E/M decision. Many orthopaedic groups perform injections at the first visit where a treatment plan is set. Under current rules and the 2027 proposal, the scheduling and clinical workflow around same-day procedures has real payment consequences, so model it by service line.
4. Model 2027 under both scenarios. Estimate the effect of a 16 percent modifier on your chronic care E/M volume and the effect of a 50 percent same-day reduction on your injection and fracture care volume. Update the model when the final rule is published.
5. Confirm payer policies. Check G2211 coverage for your top Medicare Advantage and commercial payers, and watch for their response to the 2027 changes.

Frequently asked questions

Can orthopaedic surgeons bill G2211?‍

Yes. G2211 is not restricted by specialty. An orthopaedic surgeon or APP can report it with an office or outpatient E/M visit when they are managing a patient's single serious or complex condition over time, as long as the visit is not billed with modifier 25 for a same-day separately payable procedure.

Can I bill G2211 with a joint injection on the same day?‍

Not under current Medicare rules. When the E/M is billed with modifier 25 because a separately payable procedure like 20610 was performed the same day, G2211 is not payable. The CY2025 exception applies only to same-day annual wellness visits, vaccine administration, and Medicare Part B preventive services.

Does G2211 apply to fracture care or post-operative visits?‍

Generally no. CMS lists treatment for a fracture as an example of a time-limited relationship that does not qualify, and related post-operative visits inside a global period are bundled into the surgical payment, leaving no separately payable E/M for G2211 to attach to.

Can G2211 be used on a new patient visit?‍

Yes, when the visit begins a longitudinal relationship for ongoing management of a serious or complex condition. CMS guidance refers to new or established patients. The deciding factor is the continuing care relationship, not patient status.

What documentation does G2211 require?‍

CMS does not require specific added documentation, but the record should show that the practitioner is responsible for the patient's ongoing care of a named condition and how the visit fits the longer-term plan. MAC guidance warns that generic template statements such as "patient is complex" are not enough.

Is G2211 going away in 2027?‍

CMS has proposed replacing the G2211 add-on code with a modifier that increases the E/M payment by 16 percent, or 32 percent for certain ACO participants. The proposal is not final. The CY2027 Physician Fee Schedule final rule, expected around November 2026, will determine what applies on January 1, 2027.

Where automation fits

G2211 eligibility is decided by facts already in the chart: whether a same-day procedure was performed and billed with modifier 25, whether the diagnosis reflects a chronic condition or an episodic injury, whether the date of service falls inside a global period, and whether the note documents an ongoing care relationship. Those checks are easy to miss when coders are leveling visits at volume. Maia's E/M AutoCoder reads the note inside the EHR, recommends the visit level, modifiers, and add-on codes with the clinical justification attached, and flags documentation gaps before the claim is submitted. Orthopaedic groups including Midwest Orthopaedics at Rush, OrthoIndy, and Bone and Joint Institute of Tennessee use Maia to apply these rules consistently on every visit.

See how Maia's AutoCoder handles this automatically for orthopaedic practices. Book a demo today at usemaia.com.